Monica Caronni

924 total citations
17 papers, 615 citations indexed

About

Monica Caronni is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Dermatology. According to data from OpenAlex, Monica Caronni has authored 17 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Dermatology. Recurrent topics in Monica Caronni's work include Systemic Sclerosis and Related Diseases (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Dermatologic Treatments and Research (4 papers). Monica Caronni is often cited by papers focused on Systemic Sclerosis and Related Diseases (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Dermatologic Treatments and Research (4 papers). Monica Caronni collaborates with scholars based in Italy, Netherlands and Spain. Monica Caronni's co-authors include Lorenzo Beretta, L Origgi, R Scorza, Alessandro Santaniello, Maurizio Marchini, M. Vanoli, S Bazzi, Adriana Severino, Marco Sardina and B. Mascagni and has published in prestigious journals such as Annals of the New York Academy of Sciences, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Monica Caronni

17 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monica Caronni Italy 14 406 220 184 134 111 17 615
Karin Melsens Belgium 15 606 1.5× 186 0.8× 146 0.8× 121 0.9× 265 2.4× 29 724
Angela Kill Germany 7 308 0.8× 109 0.5× 209 1.1× 103 0.8× 74 0.7× 8 549
E. Bodolay Hungary 13 354 0.9× 165 0.8× 167 0.9× 251 1.9× 41 0.4× 37 723
Katia Stefanantoni Italy 13 294 0.7× 90 0.4× 108 0.6× 53 0.4× 120 1.1× 30 416
Yuri Masui Japan 14 230 0.6× 71 0.3× 131 0.7× 55 0.4× 119 1.1× 30 452
Noémie Assous France 8 209 0.5× 84 0.4× 136 0.7× 204 1.5× 56 0.5× 11 481
Cecília Varjú Hungary 13 423 1.0× 114 0.5× 108 0.6× 130 1.0× 187 1.7× 27 605
P. Vlachoyiannopoulos Greece 13 156 0.4× 70 0.3× 151 0.8× 260 1.9× 32 0.3× 17 503
Bożena Dziankowska‐Bartkowiak Poland 12 211 0.5× 57 0.3× 86 0.5× 42 0.3× 96 0.9× 39 351
K. Mariampillai France 14 211 0.5× 148 0.7× 160 0.9× 344 2.6× 107 1.0× 28 906

Countries citing papers authored by Monica Caronni

Since Specialization
Citations

This map shows the geographic impact of Monica Caronni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Caronni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Caronni more than expected).

Fields of papers citing papers by Monica Caronni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Caronni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Caronni. The network helps show where Monica Caronni may publish in the future.

Co-authorship network of co-authors of Monica Caronni

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Caronni. A scholar is included among the top collaborators of Monica Caronni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Caronni. Monica Caronni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rodrigues, Gabriel Dias, Eleonora Tobaldini, Chiara Bellocchi, et al.. (2019). Cardiac autonomic modulation at rest and during orthostatic stress among different systemic sclerosis subsets. European Journal of Internal Medicine. 66. 75–80. 27 indexed citations
2.
Vigone, Barbara, Monica Caronni, Adriana Severino, et al.. (2017). Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study. Arthritis Research & Therapy. 19(1). 145–145. 40 indexed citations
3.
Castellani, Massimo, et al.. (2016). 18F-FDG uptake in main arterial branches of patients with large vessel vasculitis: visual and semiquantitative analysis. Annals of Nuclear Medicine. 30(6). 409–420. 12 indexed citations
4.
Cossu, Marta, Romina Andracco, Alessandro Santaniello, et al.. (2016). Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients. Lara D. Veeken. 55(6). 1112–1116. 41 indexed citations
5.
Cossu, Marta, Romina Andracco, Alessandro Santaniello, et al.. (2015). AB0204 Serum Levels of Vascular Markers Reflect Disease Severity and Stage in Systemic Sclerosis. Annals of the Rheumatic Diseases. 74. 959–959. 1 indexed citations
6.
Vigone, Barbara, Alessandro Santaniello, Maurizio Marchini, et al.. (2014). Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis. Lara D. Veeken. 54(4). 707–711. 20 indexed citations
7.
D’Amico, Fabio, Evangelia Skarmoutsou, Maurizio Marchini, et al.. (2013). Genetic polymorphisms of FOXP3 in Italian patients with systemic sclerosis. Immunology Letters. 152(2). 109–113. 24 indexed citations
8.
Santaniello, Alessandro, et al.. (2013). Carbohydrate antigen 15.3 as a serum biomarker of interstitial lung disease in systemic sclerosis patients. European Journal of Internal Medicine. 24(7). 671–676. 28 indexed citations
9.
Beretta, Lorenzo, Maurizio Marchini, Alessandro Santaniello, et al.. (2011). Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis. Lara D. Veeken. 51(1). 52–59. 40 indexed citations
10.
Beretta, Lorenzo, Simone Astori, E. Ferrario, et al.. (2011). Determinants of depression in 111 italian patients with systemic sclerosis. Reumatismo. 58(3). 219–25. 17 indexed citations
11.
Borghi, Elisa, et al.. (2009). Oropharyngolaryngeal Disorders in Scleroderma: Development and Validation of the SLS Scale. Dysphagia. 25(2). 127–138. 12 indexed citations
12.
Beretta, Lorenzo, et al.. (2007). Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology. Human Immunology. 68(7). 603–609. 28 indexed citations
13.
Beretta, Lorenzo, Monica Caronni, L Origgi, et al.. (2006). Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Scandinavian Journal of Rheumatology. 35(6). 468–471. 48 indexed citations
14.
Beretta, Lorenzo, et al.. (2006). Oral cyclophosphamide improves pulmonary function in scleroderma patients with fibrosing alveolitis: experience in one centre. Clinical Rheumatology. 26(2). 168–172. 33 indexed citations
15.
Marchini, Maurizio, Ana Lleò, Monica Caronni, et al.. (2003). Hla class II antigens assoiated with lupus nephritis in italian SLE patients. Human Immunology. 64(4). 462–468. 44 indexed citations
16.
Caronni, Monica, S Bazzi, F Nador, et al.. (2002). Post‐Menopause is the Main Risk Factor for Developing Isolated Pulmonary Hypertension in Systemic Sclerosis. Annals of the New York Academy of Sciences. 966(1). 238–246. 73 indexed citations
17.
Scorza, R, Monica Caronni, B. Mascagni, et al.. (2002). Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud's phenomenon. A randomized, controlled study.. PubMed. 19(5). 503–8. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin Melsens Breakdown of academic impact, for papers by Angela Kill Breakdown of academic impact, for papers by E. Bodolay Breakdown of academic impact, for papers by Katia Stefanantoni Breakdown of academic impact, for papers by Yuri Masui Breakdown of academic impact, for papers by Noémie Assous Breakdown of academic impact, for papers by Cecília Varjú Breakdown of academic impact, for papers by P. Vlachoyiannopoulos Breakdown of academic impact, for papers by Bożena Dziankowska‐Bartkowiak Breakdown of academic impact, for papers by K. Mariampillai
Rankless by CCL
2026